Bicarbonate

Bicarbonate

SCHEMBL4935530

CCCCN=C(C)N(C)C.O=C(O)O

nearest known ligand 0.40

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BIMPA1

The experimentally established mechanism targets of Bicarbonate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.40
DDAH1 O94760 3/20 0.38
CES1 P23141 6/20 0.37
LMNA P02545 1/20 0.36
CES2 O00748 5/20 0.36
NOS1 P29475 2/20 0.35
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
GRIN2D O15399 1/20 0.34
GRIN3B O60391 1/20 0.34
GRIN1 Q05586 1/20 0.34
GRIN2A Q12879 1/20 0.34
GRIN2B Q13224 1/20 0.34
GRIN2C Q14957 1/20 0.34
GRIN3A Q8TCU5 1/20 0.34
SIGMAR1 Q99720 1/20 0.34
AKR1B1 P15121 1/20 0.33
PPARG P37231 4/20 0.32
PPARD Q03181 4/20 0.32
PPARA Q07869 4/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bicarbonate SCHEMBL4931887 0.92 MEN1 (0.45) ALDH1A1CES1CES2MEN1KMT2A
Bicarbonate SCHEMBL4935534 0.92 MEN1 (0.45) ALDH1A1CES1CES2MEN1KMT2A
Bicarbonate SCHEMBL4938106 0.92 MEN1 (0.45) ALDH1A1CES1CES2MEN1KMT2A
Bicarbonate SCHEMBL4936724 0.92 MEN1 (0.45) ALDH1A1CES1CES2MEN1KMT2A
SCHEMBL4932978 0.91 LMNA (0.41) ALDH1A1DDAH1CES1LMNACES2
SCHEMBL4932972 0.91 LMNA (0.41) ALDH1A1DDAH1CES1LMNACES2
SCHEMBL21478076 0.85 MEN1 (0.48) ALDH1A1CES1LMNACES2NOS1
SCHEMBL20718552 0.83 MEN1 (0.52) ALDH1A1CES1LMNACES2MEN1
SCHEMBL21523293 0.83 MEN1 (0.52) ALDH1A1CES1LMNACES2MEN1
SCHEMBL21523295 0.83 MEN1 (0.52) ALDH1A1CES1LMNACES2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130087072-A1 Reversibly Switchable Surfactants and Methods of Use Thereof QUEEN'S UNIVERSITY AT KINGSTON (CA) 2013-04-11 US disclosed
US-8283385-B2 Emulsion polymerization; oil industry QUEEN'S UNIVERSITY AT KINGSTON (CA) 2012-10-09 US disclosed
US-20080197084-A1 Reversibly switchable surfactants and methods of use thereof QUEEN'S UNIVERSITY AT KINGSTON (CA) 2008-08-21 US disclosed
EP-1957434-A1 REVERSIBLY SWITCHABLE SURFACTANTS AND METHODS OF USE THEREOF QUEEN'S UNIVERSITY AT KINGSTON (CA) 2008-08-20 EP disclosed
WO-2007056859-A1 REVERSIBLY SWITCHABLE SURFACTANTS AND METHODS OF USE THEREOF QUEEN'S UNIVERSITY AT KINGSTON (CA) 2007-05-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080197084-A1 Reversibly switchable surfactants and methods of use thereof SGMS1, SGMS2, HDHD5 ALDH1A1 3854/4885DDAH1 553/4885CES1 771/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.